Accused insider trader Martoma worked at SAC Capital affiliate

NEW YORK (Reuters) - The former hedge fund manager accused of a $250 million insider trading scheme worked for some time for SAC Capital, according to sources who confirmed his employment history with Reuters on Tuesday.

Mathew Martoma, who has been charged with trading on inside information on some drug companies, worked at CR Intrinsic Investors, a unit of SAC.

His lawyer was not immediately available for comment.

(Reporting By Emily Flitter; Editing by Gerald E. McCormick)

Contact U.S. News


    Get the best of CNBC in your inbox

    › Learn More

Don't Miss

U.S. Video

  • Charles Rotblut, American Association of Individual Investors, reveals the results on an AAII survey which shows positive investment sentiment rose slightly. Most of our members take a long-term outlook, says Rotblut.

  • CNBC's Josh Lipton talks with Apple's Eddy Cue about what consumers can expect to see in Apple's latest product - Apple Pay.

  • Michael Pearson, Valeant Pharmaceuticals CEO, shares his thoughts on allegations Allergan released false and misleading information.